It is thought that the pitch has been called because of the departure of marketing director George Li, who hired incumbent DMG to handle the brands, in favour of Saatchi & Saatchi. Xian Janssen later shifted three more brands to Ogilvy & Mather, and gave one brand to Draft FCB. Gastrointestinal drug Motilium is Xian Janssen’s top brand, with media spend of Rmb 200 million (US$30 million).
Gyno-Daktarin, a thrush medication, competes against local brands such as Jie Er Yin, Fu Yin Jie and Kang Fu Te - all of which have placed TV at the core of their media strategy.
It is unclear if DMG will defend its hold on the accounts.
Xian Janssen calls for creative pitch
SHANGHAI - Xian Janssen Pharmaceutical is believed to be pitching creative duties for two of its biggest mainland brands - Gyno-Daktarin and Motilium.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
Most Read
Just Published
Omnicom cut 3,000 roles during 2024 ahead of IPG ...
Total headcount fell 1,000, as job reductions more than offset acquisition of 2000-strong Flywheel, and agency group plans further staff cuts to save US$330 million.
40 Under 40 2024: Tala Booker, Via
What does it take to build a global communications agency in a year? Ask Tala Booker, the former HSBC executive who's rewriting the rules.
Majority of marketers are unprepared to combat ...
A report from Forrester highlights the risks that companies face from deepfakes, as well as the current inadequate state of preparation to combat the problem.
The unbearable cost of truth
As information retreats behind paywalls and attention splinters into subscription tiers, advertising faces its terminal paradox: We've made truth so expensive that soon, no one will be left who can afford to buy what we're selling.